References
- Mayes M, Assassi S. Epidemiology and classification of scleroderma. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 5th ed. Philadelphia: Elsevier, 2011:1363-1366.
- Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013;65:1953-1962. https://doi.org/10.1002/art.37988
- Boin F, Wigley FM. Clinical features and treatment of scleroderma. In: Firestein GS, Budd RC, Gabriel SE, Mclnnes IB, O'dell JR, eds. Kelley's Textbook of Rheumatology. 9th ed. Philadelphia: Elsevier, 2013: 1366-1403.
- Preliminary criteria for the classification of systemic sclerosis (scleroderma): subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590. https://doi.org/10.1002/art.1780230510
- Singh JA, Solomon DH, Dougados M, et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-352. https://doi.org/10.1002/art.22003
- Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988;47:634-641. https://doi.org/10.1136/ard.47.8.634
- Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010;6:578-587. https://doi.org/10.1038/nrrheum.2010.104
- Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 1995;22:2226-2232.
- Medsger TA Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 2003;29:255-273. https://doi.org/10.1016/S0889-857X(03)00023-1
- LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-1576.
- Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-3912. https://doi.org/10.1002/art.24038
- Kim HS, Park MK, Kim HY, Park SH. Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 2010;29:247-254. https://doi.org/10.1007/s10067-009-1288-7
- Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011;70:476-481. https://doi.org/10.1136/ard.2010.136929
- Van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-2747. https://doi.org/10.1002/art.38098
- Valentini G, Marcoccia A, Cuomo G, Iudici M, Vettori S. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis. Curr Rheumatol Rev 2014 Apr 3 [Epub]. DOI:10.2174/1573397110666140404001756.
Cited by
- The Efficacy of Nailfold Capillaroscopy in Patients with Raynaud's Phenomenon vol.22, pp.2, 2014, https://doi.org/10.4078/jrd.2015.22.2.69
- The Clinical Efficacy of Nailfold Capillaroscopy in Rheumatic Diseases vol.90, pp.6, 2014, https://doi.org/10.3904/kjm.2016.90.6.494
- 전신경화증으로 유발된 속발성 레이노증후군 호전 1례 vol.31, pp.4, 2014, https://doi.org/10.6114/jkood.2018.31.4.108
- 근골격계 질환에서 진단의학검사의 활용 vol.13, pp.2, 2018, https://doi.org/10.30581/jkcmm.2018.13.2.109